Global Antifungal Agents Market

Antifungal Agents Market Size, Share, Growth Analysis, By Drug Type(Echinocandins, Azoles), By Therapeutic Indication(Aspergillosis, Dermatophytosis), By Application(Powders, Ointments) - Industry Forecast 2024-2031

Report ID: SQMIG35J2113 | Region: Global | Published Date: May, 2024
Pages: 219 | Tables: 94 | Figures: 76

To request a free sample copy of this report, please complete the form below.
What people say about us!

"We have purchased recently a report from SkyQuest Technology, and we are happy to inform you that this report was so useful and practical for our team. Skyquest Team was very active and our queries were followed up completely.It was amazing. "

- Mr. Ali Zali, Commercial Director, ICIIC Iran.

logos logos logos logos logos
Analyst Support
$5,300
BUY NOW
Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

Global Antifungal Agents Market size was valued at USD 14.4 billion in 2022 and is poised to grow from USD 14.98 billion in 2023 to USD 20.5 billion by 2031, growing at a CAGR of 4% in the forecast period (2024-2031).

Antifungal agent manufacturers should invest heavily in R&D of novel agents and drugs that can be used for a wide variety of fungal infections. Antifungal agent companies can collaborate and partner with each other to fast track the development and launch of novel products going forward. 'Asperqillus', 'Alternaria', 'Sun Pharmaceutical Industries Ltd.', 'Eli Lily Company', 'Pfizer', 'GlaxoSmithKline', 'Sumitomo Dainippon Pharma Co. Ltd.', 'Bayer Healthcare', 'Glenmark', 'Novartis', 'Cosmo Pharmaceuticals NV', 'Sanofi-Aventis', 'Astellas Pharma', 'Teva Pharmaceutical Industries Ltd.', 'Merck & Co.', 'Kramer Laboratories', 'Abbott Laboratories', 'Enzon Pharmaceuticals', 'Gilead', 'Zydus Cadila Healthcare Ltd.'

Widespread antibiotic resistance and growing incidence of infectious chronic diseases are key factors responsible for increasing fungal infections among patients, which in turn, is projected to boost antifungal agent demand outlook.

Personalized Medicine: Antifungal agent vendors can collaborate and partner with personalized medicine companies to develop specialized treatments using antifungal agents for patients affected with different kinds of fungal infections. Antifungal agents companies can take advantage of advancements in different personalized medicine approaches to maximize their revenue generation.

North America is estimated to account for a substantial share of the global antifungal agents market owing to rising cases of fungal infections in this region. of a developed healthcare infrastructure and growing investments in the R&D of novel antifungal drugs and medications are also contributing to the dominance of this segment over the coming years. Increasing cases of antifungal resistance in this region will also boost market growth going forward. The United States is forecasted to spearhead the demand for antifungal agents in the long run.

Related Reports

Fungicides Market
Buy Now GET FREE SAMPLE
Antiviral Drugs Market
Buy Now GET FREE SAMPLE
Animal Antibiotics and Antimicrobials Market
Buy Now GET FREE SAMPLE
Antimicrobial Coatings Market
Buy Now GET FREE SAMPLE
Yeast Ingredients Market
Buy Now GET FREE SAMPLE
Moringa Ingredients Market
Buy Now GET FREE SAMPLE
Antibiotics Market
Buy Now GET FREE SAMPLE
Herbal Medicine Market
Buy Now GET FREE SAMPLE

Feedback From Our Clients

Global Antifungal Agents Market

Product ID: SQMIG35J2113

$5,300
BUY NOW